Omeros Corp. Files Q1 2025 10-Q
Ticker: OMER · Form: 10-Q · Filed: May 15, 2025 · CIK: 1285819
| Field | Detail |
|---|---|
| Company | Omeros Corp (OMER) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: OMER
TL;DR
OMER Q1 2025 10-Q filed. Financials and ops details inside.
AI Summary
Omeros Corp. filed its 10-Q for the quarter ending March 31, 2025. The filing details financial performance and operational updates for the period. Specific financial figures and operational highlights are provided within the report.
Why It Matters
This filing provides investors and stakeholders with the latest financial health and strategic direction of Omeros Corp. as of the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Omeros Corp. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- OMEROS CORP (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
- SEATTLE (location) — City of Omeros Corp. headquarters
- WA (location) — State of Omeros Corp. headquarters
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed with the SEC on May 15, 2025.
What is the Standard Industrial Classification for Omeros Corp.?
The Standard Industrial Classification for Omeros Corp. is Pharmaceutical Preparations [2834].
Where is Omeros Corp. headquartered?
Omeros Corp. is headquartered at 201 Elliott Avenue West, Seattle, WA 98119.
What is the fiscal year end for Omeros Corp.?
The fiscal year end for Omeros Corp. is December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding OMEROS CORP (OMER).